Privacy Policy
Signals Blog

Contributors

Categories

Right Turn: Looking back on 10 amazing years at Signals

This month is the 10-year anniversary of when Lisa Willemse and I launched Signals. As you would imagine, blogs come and go so 10 years is a significant milestone. It is also my 10-year anniversary at CCRM and when I was introduced to the regenerative medicine field....

Right Turn: Careers in advanced manufacturing

The incredible, non-stop growth of the global cell and gene therapy market – valued at ~$12 billion by 2025 – means that talent is in high demand. (That estimate does not include tissue engineering, but it still seems low.) While seasoned professionals and those with...

Rebuilding the Canadian biomanufacturing sector

  From the H1N1 pandemic of 2009, Canada recognized it was not ready for a pandemic. “What we were not prepared for was for the pandemic to occur when it did,” said an interviewee at a panel review of Canada’s response to the 2009 H1N1 pandemic. “So, it...

Can COVID-19 be a shot in the arm for cell and gene therapy?

Phil Vanek is responsible for technical due diligence and evaluation of potential investments, as well as guiding operational, R&D and strategic initiatives carried out at portfolio companies. An entrepreneurial and strategic international business leader, Phil...